Wouter Joustra
General partner at Forbion and Board member at Gyroscope Therapeutics
Wouter Joustra is the board member at Gyroscope Therapeutics and is a general partner at Forbion. Previously, Wouter was a Senior Trader Life Sciences at Kempen, one of the leading investment banks focused on life sciences. At Kempen, Wouter was also an Executive Board member of the Life Sciences Franchise, responsible for defining and execute the niche’s strategy, budgets etc.
Visit website: https://forbion.com/en/team/wouter_joustra
See also: Gyroscope Therapeutics - London-based company developing gene therapies and delivery technologies for eye diseases
Details last updated 31-Mar-2021
Wouter Joustra News
Gyroscope secures $148M to develop treatment for rare eye diseases
Longevity Technology - 29-Mar-2021
Funds to advance gene therapy for age-related macular degeneration & innovative delivery system
Read more...